News
Ozempic, originally for type 2 diabetes, has surged in popularity in North America as a weight-loss solution, sparking a ...
Short term trials with surrogate measures instead of hard outcomes are often used to study chronic diseases. The effects of an intervention may, however, take time to develop and persist after ...
The frequency of high blood glucose among patients receiving PI3K/Akt inhibitors to treat breast cancer has some oncologists ...
College of Charleston's Kindred Hurtado examines one woman's weight-loss journey with the assistance of semaglutides.
A once-weekly dose of tirzepatide (Mounjaro) can lead to significant, sustained weight loss for up to 3 years in adults with ...
This came after Sun Pharma presented the BE study report along with revised clinical trial (CT) protocol no. ICR/23/013 ver.
Many people experience a serious return of appetite, cravings and weight after coming off Ozempic, and having read far too ...
Compared with other antidiabetic medications, semaglutide was linked to a significantly lower risk of opioid overdose in ...
GLP-1 medications like Ozempic may help reduce alcohol cravings and support recovery—especially when combined with therapy ...
2d
Worcester Telegram on MSNBlue Cross Blue Shield of Massachusetts to roll back coverage of weight loss drugsBlue Cross Blue Shield of Massachusetts, the state's largest health insurer, recently announced that it will roll back ...
4d
News-Medical.Net on MSNDiabetes drugs GLP-1RA and SGLT2i lower dementia risk in older adults, study findsA large population-based study found that GLP-1 receptor agonists (GLP-1RAs) and SGLT2 inhibitors (SGLT2is), two classes of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results